New Alzheimer's drugs are beginning to be used in Sweden, more deals in the neuro sector are expected, and tools for deliver ...

New Alzheimer's drugs are beginning to be used in Sweden, more deals in the neuro sector are expected, and tools for deliver ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...

Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

According to Mark Overbay, co-founder and president of Big Spoons Roasters, the nut butter in your pantry can help support ...

The blood–brain barrier is a highly selective shield that protects the brain from harmful substances in the bloodstream.

Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for ...

Funding for motor neurone disease (MND) research has received a boost through a unique fundraising initiative involving ...

The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...

Scientists from the University of Liverpool, and their global collaborators have highlighted the most effective treatments ...

Dr Lotta Oikari, a Senior Research Officer at QIMR Berghofer Medical Research Institute, is the recipient of the NTI MND ...